StockData
OWLTNYSEMeasuring & Controlling Devices, NECFiscal year ends December 31

Owlet, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$4.16+0.05 (+1.22%)

Close on Oct 19, 2026

Market cap
$118.62M
P/E (TTM)
–
Dividend yield
–

About Owlet

Measuring & Controlling Devices, NEC, SIC 3829

Owlet provides pediatric health and monitoring technology designed for home use. The company develops medical-grade wearable monitors and connected nursery products, including the over-the-counter Dream Sock pulse oximeter, the prescription-based BabySat monitor for infants requiring physician-directed tracking, the Dream Sight smart video and audio camera, and the integrated Dream Duo system. In addition to hardware and nursery accessories, Owlet offers the Owlet360 subscription service, which delivers health and sleep insights derived from pediatric datasets. Its offerings primarily serve parents, caregivers, and pediatric healthcare providers.

The company markets its products internationally and sells through direct-to-consumer digital platforms, retail partners, and healthcare distribution channels across more than thirty countries, including the United States, Canada, Australia, the United Kingdom, and members of the European Union. Over 2.5 million Owlet devices have been sold globally. Owlet does not disclose the location of its corporate headquarters in the provided text.

Summary of the business section of Owlet's latest annual report, written by StockData.

Company profile

Company

Legal name
Owlet, Inc.
Founded
2012
Headquarters
Lehi, UT
Address
2940 West Maple Loop Drive, Suite 203 84048
Phone
(844) 334-5330
Employees
108, Dec 31, 2025
Industry
Measuring & Controlling Devices, NEC
Incorporated in
Delaware
Fiscal year ends
December 31
Auditor
PricewaterhouseCoopers LLP, Salt Lake City, Utah

Stock & identifiers

Ticker
OWLT
Exchange
NYSE
IPO date
Sep 16, 2020
Shares outstanding
29M, Aug 6, 2026
Public float
$95.60M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company
Stock splits
1-for-14 reverse, Jul 10, 2023; 1-for-14 reverse, Jul 7, 2023
SEC CIK
1816708
CUSIP
69120X206
ISIN
US69120X2062
EIN
00-0000000

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Kurt WorkmanPresident & CEO3,285,279
Amanda CrawfordChief Financial Officer212,800
Zane M. BurkeDirector134,787
Marc F. StollDirector45,781
Laura DurrDirector127,454
John C. KimDirector278,811
Melissa GonzalesDirector114,690
Eclipse Continuity Fund I, L.P.Director28,492,332
Lior SusanDirector5,665,669
Eclipse Continuity GP I, LLCDirector–
Eclipse Ventures Fund I, L.P.Director5,665,669
Eclipse Ventures GP I, LLCDirector–
Eclipse Early Growth GP I, LLCDirector–
Eclipse Early Growth Fund I, L.P.Director1,066,472

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Jonathan Harris
$4.23M$7.73M$2.42M$207–
FY2025
Kurt Workman
$799.41K$1.25M$2.42M$207–
FY2024
Kurt Workman
$987.07K$920.15K$1.07M$57–
FY2023
Kurt Workman
$269.13K-$88.45K$687.40K$67–

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had 108 full-time employees and 6 part-time employees.”

Corporate history

Events identified from SEC filings